709 related articles for article (PubMed ID: 7476965)
1. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists.
Montano MM; Müller V; Trobaugh A; Katzenellenbogen BS
Mol Endocrinol; 1995 Jul; 9(7):814-25. PubMed ID: 7476965
[TBL] [Abstract][Full Text] [Related]
2. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
[TBL] [Abstract][Full Text] [Related]
3. Activation of transcriptionally inactive human estrogen receptors by cyclic adenosine 3',5'-monophosphate and ligands including antiestrogens.
Ince BA; Montano MM; Katzenellenbogen BS
Mol Endocrinol; 1994 Oct; 8(10):1397-406. PubMed ID: 7531820
[TBL] [Abstract][Full Text] [Related]
4. Identification of charged residues in an N-terminal portion of the hormone-binding domain of the human estrogen receptor important in transcriptional activity of the receptor.
Pakdel F; Reese JC; Katzenellenbogen BS
Mol Endocrinol; 1993 Nov; 7(11):1408-17. PubMed ID: 8114756
[TBL] [Abstract][Full Text] [Related]
5. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators.
Cho H; Katzenellenbogen BS
Mol Endocrinol; 1993 Mar; 7(3):441-52. PubMed ID: 7683375
[TBL] [Abstract][Full Text] [Related]
6. Regulation of pS2 gene expression by affinity labeling and reversibly binding estrogens and antiestrogens: comparison of effects on the native gene and on pS2-chloramphenicol acetyltransferase fusion genes transfected into MCF-7 human breast cancer cells.
Weaver CA; Springer PA; Katzenellenbogen BS
Mol Endocrinol; 1988 Oct; 2(10):936-45. PubMed ID: 2460749
[TBL] [Abstract][Full Text] [Related]
7. A transcriptionally active estrogen receptor mutant is a novel type of dominant negative inhibitor of estrogen action.
McInerney EM; Ince BA; Shapiro DJ; Katzenellenbogen BS
Mol Endocrinol; 1996 Dec; 10(12):1519-26. PubMed ID: 8961262
[TBL] [Abstract][Full Text] [Related]
8. Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells.
Kim K; Thu N; Saville B; Safe S
Mol Endocrinol; 2003 May; 17(5):804-17. PubMed ID: 12576490
[TBL] [Abstract][Full Text] [Related]
9. Examination of the DNA-binding ability of estrogen receptor in whole cells: implications for hormone-independent transactivation and the actions of antiestrogens.
Reese JC; Katzenellenbogen BS
Mol Cell Biol; 1992 Oct; 12(10):4531-8. PubMed ID: 1406642
[TBL] [Abstract][Full Text] [Related]
10. Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation.
McInerney EM; Katzenellenbogen BS
J Biol Chem; 1996 Sep; 271(39):24172-8. PubMed ID: 8798658
[TBL] [Abstract][Full Text] [Related]
11. Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: role of estrogen receptor Sp1 complex formation.
Duan R; Porter W; Safe S
Endocrinology; 1998 Apr; 139(4):1981-90. PubMed ID: 9528985
[TBL] [Abstract][Full Text] [Related]
12. Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF).
Klinge CM
J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):1-19. PubMed ID: 10619353
[TBL] [Abstract][Full Text] [Related]
13. Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein.
Weis KE; Ekena K; Thomas JA; Lazennec G; Katzenellenbogen BS
Mol Endocrinol; 1996 Nov; 10(11):1388-98. PubMed ID: 8923465
[TBL] [Abstract][Full Text] [Related]
14. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.
Gee AC; Carlson KE; Martini PG; Katzenellenbogen BS; Katzenellenbogen JA
Mol Endocrinol; 1999 Nov; 13(11):1912-23. PubMed ID: 10551784
[TBL] [Abstract][Full Text] [Related]
15. Alteration in the agonist/antagonist balance of antiestrogens by activation of protein kinase A signaling pathways in breast cancer cells: antiestrogen selectivity and promoter dependence.
Fujimoto N; Katzenellenbogen BS
Mol Endocrinol; 1994 Mar; 8(3):296-304. PubMed ID: 7517003
[TBL] [Abstract][Full Text] [Related]
16. Mutagenesis of cysteines in the hormone binding domain of the human estrogen receptor. Alterations in binding and transcriptional activation by covalently and reversibly attaching ligands.
Reese JC; Katzenellenbogen BS
J Biol Chem; 1991 Jun; 266(17):10880-7. PubMed ID: 2040605
[TBL] [Abstract][Full Text] [Related]
17. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
Pink JJ; Jordan VC
Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
[TBL] [Abstract][Full Text] [Related]
19. Expression of human estrogen receptor using an efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast carcinoma cells.
Lazennec G; Katzenellenbogen BS
Mol Cell Endocrinol; 1999 Mar; 149(1-2):93-105. PubMed ID: 10375022
[TBL] [Abstract][Full Text] [Related]
20. Hormone binding and transcription activation by estrogen receptors: analyses using mammalian and yeast systems.
Katzenellenbogen BS; Bhardwaj B; Fang H; Ince BA; Pakdel F; Reese JC; Schodin D; Wrenn CK
J Steroid Biochem Mol Biol; 1993 Dec; 47(1-6):39-48. PubMed ID: 8274440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
